Myriad Genetics, Inc. (MYGN) - Product Pipeline Analysis

GlobalData
November 28, 2012
58 Pages - SKU: GBDT4925602


Summary

Myriad Genetics, Inc. (Myriad) is a molecular diagnostic company. The company undertakes the development and commercialization of small molecular diagnostic products. The company offers different medicine products to improve patient’s health such as predictive medicine, prognostic medicine and personalized medicine products in the areas of oncology and CNS related disorders. Its commercial molecular diagnostic tests comprise BRACAnalysis, COLARIS, MELARIS, PANEXIA, OnDose, COLARIS AP, PREZEON, TheraGuide, TruCulture, DiscoveryMAP, Prolaris and RodentMap The company along with its subsidiaries operates in the US, Spain, France, Switzerland and Italy.The company is headquartered in Salt Lake City, Utah, the US.

The company's strategy is to understand the relationship between genes, protein products and human diseases for the development of the next generation molecular diagnostic tests.

This report is a source for data, analysis and actionable intelligence on the Myriad Genetics, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope
  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.
Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.



More M - Companies reports by GlobalData

Mutual of Omaha Insurance Company - Strategic SWOT Analysis Review by GlobalData
Mutual of Omaha Insurance Company - Strategic SWOT Analysis Review - provides a comprehensive insight into the company’s history, corporate strategy, business structure and ...
Minnesota Life Insurance Company - Strategic SWOT Analysis Review by GlobalData
Minnesota Life Insurance Company - Strategic SWOT Analysis Review - provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. ...
Metso Corporation (MEO1V) - Financial and Strategic SWOT Analysis Review by GlobalData
Metso Corporation (MEO1V) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. ...
Marafiq - Power Plants and SWOT Analysis, 2014 Update by GlobalData
Marafiq - Power Plants and SWOT Analysis, 2014 UpdateSummaryThe report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and ...
See all reports like this >>

 

SELECT A LICENSE

    Online Download  USD 750  
    Site License  USD 1,500  
    Global Site License  USD 2,250  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!